M. Lopresti

Prenatal Maternal Physical Activity and Stem Cells in Umbilical Cord Blood.

I‐Min Lee, D. Trichopoulos, S. Onoyama, 2016, Medicine and science in sports and exercise.

Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy

Annette S. Kim, J. Butera, P. Quesenberry, 2019, British journal of haematology.

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study

David A. Edmondson, A. Stuckey, M. Lopresti, 2021, Breast Cancer Research and Treatment.

Effect of preeclampsia on umbilical cord blood stem cells in relation to breast cancer susceptibility in the offspring.

Hoi Pang Low, Chien-I Chang, Mats Lambe, 2015, Carcinogenesis.

Sexuality, fertility and pregnancy following breast cancer treatment.

M. Lopresti, D. Dizon, T. Rizack, 2018, Gland surgery.

Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary Clinic

M. Lopresti, D. Dizon, K. Leonard, 2019, Annals of Surgical Oncology.

Treatment-induced sarcoidosis in a patient with metastatic clear cell ovarian cancer

M. Lopresti, Andrew Hsu, R. Masel, 2021, BMJ Case Reports.

Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Yihong Wang, A. Brodsky, M. Lopresti, 2017, Clinical breast cancer.

Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice

M. Lopresti, Justin P Huynh, Christine M Berard-Collins, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.